Eterna Therapeutics's total assets for Q2 2026 were $6.32M, a decrease of -40.10% from the previous quarter. ERNA total liabilities were $3.12M for the fiscal quarter, a -15.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.